Giving Voice to Pancreatic Cancer Patients
By Steven Grossman, MD, PhD Pancreatic cancer is an outlier among cancers, fiercely resisting almost every scientific advance researchers...
By Steven Grossman, MD, PhD Pancreatic cancer is an outlier among cancers, fiercely resisting almost every scientific advance researchers...
Factors such as a dense tumor microenvironment, a lack of precise symptoms, and hard-to-target genetic mutations make pancreatic cancer...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a grim prognosis. While early-stage PDAC may be removed by...
The screen goes blue, that unmistakable tune starts playing, and the voice of Johnny Gilbert announces, “This. Is. Jeopardy!” We meet the contestants. We hear...
Pancreatic cancer is notoriously challenging to treat, due largely to the fact that the disease is often diagnosed after...
Supreme Court Justice Ruth Bader Ginsburg is not among us today. Sadly, we lost this iconic, trailblazing leader, who was the...
In the final days of 2019, the U.S. Food and Drug Administration (FDA) expanded the use of a previously...
Pancreatic cancer is projected to become the second leading cause of cancer mortality in the United States by 2030....
A recent blog post by the Sidney Kimmel Cancer Center – Jefferson Health examined whether the power of immunotherapy...
Pancreatic cancer is a deadly disease with a five-year survival rate of a mere 8.2 percent, according to statistics...